Table 6. Tumour response.

	Cisplatin–gemcitabine		Epirubicin–gemcitabine
Response	No.	%	No.	%	P
Complete response	1	1	0	0
Partial response	54	45	44	36
Stable disease	40	34	37	31
Progressive disease	22	19	26	22
Not assessable	2	2	14	12
Overall response (95% CI)		46 (37–55)		36 (28–45)	0.121